Health Care/Hospital

Yayi International Inc. Reaffirms its Commitment to Quality and Safety

TIANJIN, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ -- Yayi International Inc. (“Yayi Intl.” or the “Company”) (OTC Bulletin Board: AHLN) today reaffirmed its commitment to product quality and safety, and will strictly control all the operational procedures to make sure that no contamin...

2008-09-17 21:00 506

China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII

TAIAN CITY, Shandong, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Comp...

2008-09-17 20:00 672

Gefitinib (IRESSA)(TM) Shows Superior Efficacy Compared to Doublet Chemotherapy in Phase III Asian 1st Line Advanced Non-Small Cell Lung Cancer (NSCLC) Study

HONG KONG, Sept. 19 /Xinhua-PRNewswire/ -- Data presented at the European Society of Medical Oncology (ESMO) meeting in Stockholm show that the IRESSA Pan-ASia Study (IPASS) exceeded its primary objective, demonstrating superior progression-free survival (PFS) for the oral anti-cancer drug gef...

2008-09-19 16:00 1007

GfK Asia Releases First Ever Taiwan Contact Lens Industry Retail Measurement

Taiwan Consumer Retail Contact Lens sales to reach USD200 Million by Year End 2008 SINGAPORE, Sept. 17 /Xinhua-PRNewswire/ -- GfK Asia releases its first ever Taiwan contact lens retail measurement for the optical industry today. The initial report estimates the total value of Taiwan conta...

2008-09-17 15:35 616

Synutra to Commence Product Recall

'Super' Products Not Involved in Recall QINGDAO, China and ROCKVILLE, MD, Sept. 17 /Xinhua-PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT, "Synutra"), a leading infant formula company in China, and a producer, marketer and seller of nutritional products for infants, children and adu...

2008-09-17 05:51 523

3SBio Inc. to Present at the UBS Global Life Sciences Conference

SHENYANG, China, Sept. 17 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that David Chen, Chief Operating Officer, will present at the UBS G...

2008-09-17 05:38 596

Mindray to Hold Annual General Meeting in Hong Kong on October 17, 2008

SHENZHEN, China, Sept. 17 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide today announced that it will hold its 2008 annual general meeting of record at the Company’s Hong Kong office, Room 2813 ...

2008-09-17 05:00 551

More People With Down Syndrome Are Being Born, Achieving More and Living Longer Than Ever Before

PORTSMOUTH, England, Sept. 16 /Xinhua-PRNewswire/ -- A new analysis shows that many more babies are being born with Down syndrome today than 15 years ago in England, despite universally available genetic screening. More people are living with Down syndrome today than ever before. They are achi...

2008-09-16 11:00 609

Sinovac to Present at the 2008 UBS Global Life Sciences Conference

BEIJING, Sept. 17 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that Mr. Weidong Yin, Chairman, president & CEO, will present at 2008 UBS Global Life Sciences Conference, at Grant Hyatt Beijing Hotel in New York City. The Pr...

2008-09-17 20:00 695

Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine

BEIJING, Sept. 16 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the initiation of clinical trials in Ukraine for its inactivated hepatitis A vaccine, Healive, in September, 2008. The trials are being conducted by Biolik Biophar...

2008-09-15 20:00 707

Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources

NANJING, China, Sept. 12 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announces the promotions of Mr. Jindong Zhou and ...

2008-09-12 17:11 660

China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company

HARBIN, China, Sept. 12 /Xinhua-PRNewswire/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Amex: CSY), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Republic of China ("PRC"), announced today that it completed the a...

2008-09-12 04:26 575

Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million

LAIYANG, China, Sept. 12 /Xinhua-PRNewswire/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a leading pharmaceutical company in the People’s Republic of China, today announced that the Company received purchase orders for a total value of ...

2008-09-12 03:01 568

AVAiL Study Shows Longest Survival in Patients With Advanced non-Small Cell Lung Cancer

-- Final Analysis of Study Confirms Benefit of Avastin(R) for Patients With Lung Cancer BASEL, Switzerland, Sept. 15 /Xinhua-PRNewswire/ -- The final analysis of the Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown that not only did the drug significa...

2008-09-15 21:25 541

Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer

-- Avastin Shows Unprecedented Patient Benefits Regardless of K-Ras Status, Age and Chemotherapy Choice BASEL, Switzerland, Sept. 12 /Xinhua-PRNewswire/ -- Avastin's (bevacizumab) essential role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second mos...

2008-09-12 15:00 655

Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets

Launch Scheduled for November 2008 CHENGDU, China, Sept. 11 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine (“TCM”) based in Chengdu, China, today announced that the Compan...

2008-09-11 20:30 680

Fenofibrate Reduces the Risk of Amputations in Patients With Type 2 Diabetes

- Exciting New Data From the FIELD Study Show Additional Microvascular-Associated Benefits of Fenofibrate - The First Time in a Large-Scale Prospective Study That any Lipid-Modifying Therapy has Been Shown to Significantly Reduce the Risk of Lower-Limb Amputation in Patients With Type 2 D...

2008-09-11 17:50 483

Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season

BEIJING, Sept. 11 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the market launch of Anflu(R), a seasonal influenza vaccine, for 2008-2009 Flu Season. Developed and manufactured by Sinovac, Anflu(R) is the only split influenz...

2008-09-11 09:47 750

Quintiles Expands Base for Growing Asia-Pacific Operations

New building in Singapore is home of region's largest clinical development organization RESEARCH TRIANGLE PARK, N.C., Sept. 11 /Xinhua-PRNewswire/ -- Quintiles Transnational Corp. announced today that it will expand its Singapore operations to meet the surging demand for its business ...

2008-09-11 14:56 693

Shengtai Pharmaceutical to Present at Upcoming Investors Conferences

- Rodman and Renshaw Annual Global Investment Conference in New York City - Roth Capital’s China Comes to Vegas Conference in Las Vegas WEIFANG, Shandong, China, Sept. 11 /Xinhua-PRNewswire/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" ...

2008-09-11 04:00 603
1 ... 704705706707708709710 ... 759